Metraipolis › archive › dc_b229170dc03d

Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: An Inverse Probability of Treatment Weighted Analysis — Europe PMC PMID:41514546

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41514546
DOI
10.3390/cancers18010033
License (as archived)
solo-consultazione
Archived
2026-11-07T11:46:36.194Z
SHA-256 of the archived text
47afb1abb94e7da2670f293c8980f738507cd72113f9722006bdb7466fef5925
Stable URL of this page
https://metraipolis.com/documento/dc_b229170dc03d

How to cite

Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: An Inverse Probability of Treatment Weighted Analysis — Europe PMC PMID:41514546 — Europe PMC (en), https://europepmc.org/article/MED/41514546 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b229170dc03d (Metraipolis archive dc_b229170dc03d, sha256 47afb1abb94e7da2670f293c8980f738507cd72113f9722006bdb7466fef5925)
BibTeX
@misc{dcb229170dc03d,
  title = {Atezolizumab Plus Bevacizumab for Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: An Inverse Probability of Treatment Weighted Analysis — Europe PMC PMID:41514546},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41514546},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b229170dc03d; sha256 47afb1abb94e7da2670f293c8980f738507cd72113f9722006bdb7466fef5925},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41514546. Agents can read the archived copy with the MCP tool read_document.